基于纤维囊激活蛋白质的放射性药物 瘤实践中的蛋白质抑制剂
1Nonprofit Organization National Cancer Institute of Ministry of Health of Ukraine, 33/43 Julia Zdanovska Str., Kyiv, 03022, Ukraine.
Problemy radiatsiinoi medytsyny ta radiobiolohii
|December 28, 2023
概括
新的纤维细胞激活蛋白 (FAP) 抑制剂作为放射性核酸标记剂在各种癌症中显示出诊断效果,可比或优于18F-FDG PET/CT. 这些FAP抑制剂为癌症诊断和治疗提供了优势.
科学领域:
- 核医学是一种核医学.
- 在瘤学瘤学.
- 放射性药物化学 放射性药物化学
背景情况:
- 纤维细胞激活蛋白 (FAP) 是瘤微环境中癌症相关纤维细胞的标记物.
- FAP抑制剂 (FAPI) 是一种新型的放射性核酸标记物,具有诊断和治疗的潜力.
- 目前的诊断方法,如18F-FDG PET/CT有其局限性.
研究的目的:
- 审查FAP抑制剂在瘤学中的应用作为放射性核酸标记剂.
- 与现有方法相比,评估基于FAPI的正子发射断层扫描/计算机断层扫描 (PET/CT) 的诊断疗效.
- 探索FAPI放射性药物 (RP) 在癌症诊断中的优势.
主要方法:
- 对FAP抑制剂和其在放射性核酸成像中的应用现有文献的审查.
- 对FAPI PET/CT与18F-氧糖 (FDG) PET/CT的诊断性能进行比较.
- 对FAPI放射性药物的特性和潜在益处的分析.
主要成果:
- 为了诊断和治疗目的,FAPI可以用各种放射性核素进行标记.
- 在各种癌症中,FAPI PET/CT的诊断效果与18F-FDG PET/CT相似或更高.
- 与18F-FDG相比,FAPI RP提供了优势,包括没有特殊准备,快速成像,高对比度和某些代谢区域的敏感度增加.
结论:
- 在所有阶段,FAPI PET/CT是传统瘤诊断的有前途的补充.
- 当18F-FDG不合适时,FAPI PET/CT可能特别有价值.
- 需要进一步的前性研究来充分评估FAPI RP的疗效,并确定临床适应症.
更多相关视频
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
![An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F66708.jpg&w=3840&q=50)

